The treatment of kala-azar in the Sudan with sodium stibogluconate: a randomized trial of three dosage regimens
β Scribed by E.E Zijlstra; M.Siddig Ali; A.M El-Hassan; H.W.Chr Hofland; I El-Toum; M Satti; H.W Ghalib
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 424 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0035-9203
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Objectives: The efficacy and tolerability of sodium valproate 2 x 240 mg compared to placebo were investigated in aggressive behavior in dementia. ## Design: A randomized, placebo controlled, double-blind cross-over design. the trial included a baseline period (one week); a placebo period (thr
## Abstract ## BACKGROUND Anemia in patients receiving chemotherapy can be ameliorated with recombinant human erythropoietin (rHuEPO), which is administered one to three times per week. Darbepoetin Ξ±, a new erythropoietic agent, has longer serum residence time, allowing it to be administered less
is a member of the speaker's bureaus at Ortho Biotech (Bridgewater, NJ) and Amgen Inc. (Thousand Oaks, CA).